Normobaric oxygen: a novel approach for treating chronic cerebral circulation insufficiency

Area of Science:

• Neurology
• Cerebrovascular Diseases
• Oxygen Therapy

Background:

• Chronic cerebral circulation insufficiency (CCCI) involves reduced brain perfusion, leading to neurological deficits and stroke risk.
• CCCI is common in cerebrovascular patients, posing management challenges.
• Normobaric oxygen (NBO) therapy increases oxygen pressure and blood flow, with proven benefits in acute stroke.

Purpose of the Study:

• To explore the potential of NBO as a therapeutic strategy for CCCI.
• To investigate NBO's efficacy in improving short-term symptoms and long-term outcomes in CCCI patients.

Main Methods:

• This study is a hypothesis-generating review based on existing literature.
• It speculates on NBO's applicability to CCCI by comparing shared mechanisms with acute stroke penumbra.

Main Results:

• NBO demonstrates neuroprotective effects, enhances blood-brain barrier integrity, and increases cerebral blood flow.
• These effects suggest potential benefits for ischemic-hypoxic brain tissues in CCCI.

Conclusions:

• NBO shows promise as a potential treatment for CCCI.
• Further experimental and clinical studies are essential to validate the efficacy and safety of NBO for CCCI management.